Volume 23, Issue 9, pp. 65-6614 September 2011
BUBENDORF, Switzerland (September 14, 2011) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, was featured on Pharmaceutical Technology Europe (Volume 23, Issue 9, pp. 65-66).
Mark Griffiths, CEO of CARBOGEN AMCIS, was invited to contribute to the section of the magazine covering Highly Potent API Manufacturing. Mr. Griffiths has a broad expertise in High Potency; he managed the design and the construction of the (i) CARBOGEN AMCIS’ High Potency Plant in Bubendorf, Switzerland for the niche supply of Highly Potent APIs (HPAPIs) and (ii) the Dishman Group’s two large-scale manufacturing facilities for commercial supply (up to multi-tonnes scale) of HPAPIs in Shanghai, China and in Ahmedabad, India.
The article is published on Pharmaceutical Technology’s CPhI Preview issue or it can be viewed on line: http://pharmtech.findpharma.com/pharmtech/Ingredients/Highly-Potent-Highly-Challenging/ArticleStandard/Article/detail/737348
If you would like to discuss directly with Mark or one of our representatives how we can assist you with your HPAPIs requirements, visit us at CPhI Stand 42C04 (Hall 4.1) in Frankfurt from 25-27 October 2011.
CARBOGEN AMCIS AG (www.carbogen-amcis.com) is a leading service provider, offering a portfolio of drug-development and commercialization services to the pharmaceutical and biopharmaceutical industry at all stages of drug development. The integrated services provide innovative chemistry solutions to support timely and safe drug development allowing customers to make the best use of available resources. CARBOGEN AMCIS AG is owned by Dishman Pharmaceuticals and Chemicals Ltd. (www.dishmangroup.com), Ahmedabad, India.
Pharmaceutical Technology (www.pharmtech.findpharma.com) is a monthly magazine published by Advanstar Communications, Inc. with a total qualified circulation of 38,600, according to their website. Pharmaceutical Technology covers process development, manufacturing, formulation and drug delivery, API synthesis, analytical technology and testing, packaging, IT, outsourcing, and regulatory compliance in the pharmaceutical and biotechnology industries.